Investors

AnaViRx is currently privately funded and is seeking early stage investment to enable the company to migrate our products to the clinic. If you would like information on investment in the company please contact Sean Reineke (CEO) at investor@anavirxus.com or call us at 301-740-1730.

[Home] [Antiviral Platform] [Influenza] [Flavivirus Infections] [Benefits of AnaViRx compounds] [Careers] [Contact Us] [Investors]